Matrix Capital Management Company, LP 4
4 · Aura Biosciences, Inc. · Filed May 11, 2026
Research Summary
AI-generated summary of this filing
Aura (AURA) 10% Owner Matrix Capital Sells 6.92M Shares
What Happened
Matrix Capital Management Company, LP (reported as a 10% owner) sold 6,922,870 shares of Aura Biosciences, Inc. (AURA) on May 7, 2026 at $5.64 per share, for total proceeds of $39,044,987. The filing lists the transaction as an S (sale) via "open market or private sale." This is a disposition of shares (a sale), not a purchase.
Key Details
- Transaction date and price: 2026-05-07 — 6,922,870 shares at $5.64 each; proceeds $39,044,987.
- Transaction code: S = Sale (open market or private sale as reported).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Filing date: 2026-05-11 (filed four days after the trade); appears late relative to the typical two-business-day Form 4 deadline.
- Footnotes: Securities are held by Matrix Capital Management Master Fund, LP; Matrix Capital Management Company, LP is the investment manager and David E. Goel is the Managing General Partner. The reporting persons disclaim beneficial ownership except to the extent of pecuniary interest.
Context
This is institutional 10%‑owner activity (fund-level), not an executive/director purchase or sale — institutional sales can reflect portfolio management rather than a view on company fundamentals. The filing’s footnotes clarify the fund/manager relationship and include a disclaimer of beneficial ownership beyond pecuniary interest. The late filing may warrant monitoring for any amendment or additional disclosure.
Insider Transaction Report
- Sale
Common Stock, par value $0.00001 per share (Common Stock)
[F1][F2]2026-05-07$5.64/sh−6,922,870$39,044,987→ 0 total(indirect: See footnotes)
Footnotes (2)
- [F1]The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.
- [F2]The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.